Publications

These Key Telehealth Policy Changes Would Improve Buprenorphine Access While Advancing Health Equity

Author(s): 

Utsha Khatri, Seth Clark, Corey Davis, Noa Krawczyk, Ulrike Muench, Michael Lynch, Justin Berk, Joanne Spetz, and Elizabeth Samuels

Date: 
September 11, 2020

Suspected opioid overdose deaths are surging during the COVID-19 pandemic, increasing by more than 40 percent in May and continuing to rise. The short-term emergency authorizations for audio-only buprenorphine treatment during COVID-19 have helped us reach people previously unable to access treatment, and these changes should be made permanent.